пользователь 1
Imatinib is a breakthrough medication primarily used in the treatment of chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs). It belongs to a class of drugs known as tyrosine kinase inhibitors, which work by blocking specific enzymes that promote the growth of cancer cells. By targeting the BCR-ABL protein—a key factor ...